| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Director | Common Stock | 6.25K | $160K | $25.56 | Jun 11, 2025 | Direct |
| Bicara Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23.7K | Jun 9, 2025 | Direct | ||
| Tyra Biosciences, Inc. | Director | Stock Option (Right to Buy) | 22.2K | May 29, 2025 | Direct | ||
| Septerna, Inc. | Director | Stock Option (Right to Buy) | 16.6K | Jun 17, 2025 | Direct | ||
| Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 11.7K | Jun 11, 2025 | Direct | ||
| DICE Therapeutics, Inc. | Director | Stock Option (right to buy Common Stock) | 0 | Aug 9, 2023 | Direct |